Sprague Word

The future and more from Richard Sprague

Posted by sprague on May 20, 2004

Biotech investing is one great big casiono: WSJ.com – Biotech’s Dismal Bottom Line: More Than $40 Billion in Losses

But is this the entire story? I wonder if the estimate counts drugs or discoveries that end up being sold to Big Pharma and move ahead profitably after that. If a biotech company is purchased by an “ordinary” drug firm, does this index consider that to be the end of the biotech part of that story?

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: